Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections [Clinical Therapeutics]

Shields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Kreiswirth, B. N., Clancy, C. J.
The American Society for Microbiology (ASM)
Published 2018
Publication Date:
2018-04-27
Publisher:
The American Society for Microbiology (ASM)
Print ISSN:
0066-4804
Electronic ISSN:
1098-6596
Topics:
Biology
Medicine
Published by: